5 things to know about Gossamer Bio, a biotech with a surprisingly diverse pipeline
2019-02-03
Gossamer Bio, Inc., a company with six drugs in its pipeline, is planning to go public and has applied to list on the Nasdaq exchange under the ticker symbol “GOSS.” Three of the company’s drugs are in clinical trials, while the rest are still in preclinical stages of development. TheRead More →
